R&D, Pharmacovigilance & Regulatory Affairs
R&D, Pharmacovilance & Regulatory Affairs
Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.
| Title | Location | Date |
Req ID
|
|
|---|---|---|---|---|
|
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases
Europe, IT
Jul 11, 2026
6111
|
||||
|
Specialist, Labelling & Compliance Regulatory Affairs, Global Rare Diseases
Parma, IT
Jul 11, 2026
7364
|
||||